癌症患者围术期肠道菌群与神经精神症状关系的研究进展

doi:10.11904/j.issn.1002-3070.2022.05.014

Abstract

Abstract: Cancer is the main cause of death in China,and its pathogenesis is complex and has not been fully elucidated.Surgery is the main treatment of cancer,and the abnormal neuropsychiatric symptoms during the perioperative period of cancer patients often affect their prognosis.In recent years,numerous studies have found that gut microbiota play an important role in the occurrence and development of perioperative neuropsychiatric symptoms in cancer patients.This article aims to describe the research status of the relationship between intestinal flora and neuropsychiatric symptoms in cancer patients during perioperative period,in order to provide a new breakthrough for cancer prevention and treatment from the perspective of intestinal flora.

Key words: Cancer, Perioperative period, Gut microbiota, Neuropsychiatric symptoms

CLC Number:

CHEN Yali, LIU Ting, CHEN Juan, DU Qiujing. Research progress on the relationship between perioperative intestinal flora and neuropsychiatric symptoms in cancer patients[J]. Journal of Practical Oncology, 2022, 36(5): 468-471.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: http://journal09.magtechjournal.com/Jwk3_syzlxzz/EN/10.11904/j.issn.1002-3070.2022.05.014

http://journal09.magtechjournal.com/Jwk3_syzlxzz/EN/Y2022/V36/I5/468

References

1 Matson V,Chervin CS,Gajewski TF.Cancer and the microbiome-influence of the commensal microbiota on cancer,immune responses,and immunotherapy[J].Gastroenterology,2021,160(2):600-613.
2 Helmink BA,Khan MAW,Hermann A,et al.The microbiome,cancer,and cancer therapy[J].Nat Med,2019,25(3):377-388.
3 Tong J,Zhang X,Fan Y,et al.Changes of intestinal microbiota in ovarian cancer patients treated with surgery and chemotherapy[J].Cancer Manag Res,2020,12(3):8125-8135.
4 Luan C,Miao H,Zhu B.Gut mycobiota and adenomas[J].Gut Microbes,2015,6(5):331-333.
5 Lee S,Park YS,Chang WJ,et al.Clinical implication of liquid biopsy in colorectal cancer patients treated with metastasectomy[J].Cancers(Basel),2021,13(9):2231.
6 Vilkoen KS,Dakshinamurthy A,Goldberg P,et al.Quantitative profiling of colorectal cancer-associated bacteria reveals associations between fusobacterium spp.,enterotoxigenic Bacteroides fragilis(ETBF)and clinicopathological features of colorectal cancer[J].PLoS One,2015,10(3):119-162.
7 Wang T,Cai G,Qiu Y,et al.Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers[J].ISME J,2018,6(2):320-329.
8 Rogers AB.Distance burning:How gut microbes promote extraintestinal cancers[J].Gut Microbes,2018,2(1):52-57.
9 Sung H,Ferlay J,Siegel RL,et al.Global Cancer Statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2021,71(3):209-249.
10 Goedert JJ,Hua X,Bielecka A,et al.Postmenopausal breast cancer and oestrogen associations with the IgA-coated and IgA-noncoated faecal microbiota[J].Br J Cancer,2018,118(4):471-479.
11 Liu Y,Jiang H.Compositional differences of gut microbiome in matched hormone-sensitive and castration-resistant prostate cancer[J].Transl Androl Urol,2020,9(5):1937-1944.
12 Luo W,Cao Z,Qiu J,et al.Novel discoveries targeting pathogenic gut microbes and new therapies in pancreatic cancer:does pathogenic E.coli infection cause pancreatic cancer progression modulated by TUBB/Rho/ROCK signaling pathway? a bioinformatic analysis[J].Biomed Res Int,2020,10(4):23-29.
13 Singh V,Kattepur A,Patil A,et al.EPEN-27.Perioperative outcomes in pediatric ependymomas-a retrospective analysis of 47 patients[J].Neuro Oncol,2018,20(Suppl 2):78-79.
14 Cui B,Su D,Li W,et al.Effects of chronic noise exposure on the microbiome-gut-brain axis in senescence-accelerated prone mice:implications for Alzheimer's disease[J].J Neuroinflammation,2018,15(1):190.
15 Serbanescu MA,Mathena RP,Xu J,et al.General anesthesia alters the diversity and composition of the intestinal microbiota in mice[J].Anesth Analg,2019,129(4):e126-e129.
16 Maifeld A,Bartolomaeus H,Löber U,et al.Fasting alters the gut microbiome reducing blood pressure and body weight in metabolic syndrome patients[J].Nat Commun,2021,12(1):1970.
17 李岷,吴信华,曹园.采用高通量测序技术研究抗生素对小鼠肠道菌群的影响[J].中国微生态学杂志,2019,31(9):993-999.
18 何艳,金孝岠.围术期患者肠道菌群失调相关因素及其与术后并发症的关系研究进展[J].新乡医学院学报,2021,129(8):73-76.
19 刘春芳,王孜恒,杨婷婷,等.乳腺癌病人手术前后抑郁症状与肠道益生菌的相关性研究[J].右江民族医学院学报,2021,234(3):83-86.
20 景双艳.肠道微生态与癌症患者抑郁症发生关系的研究进展[J].国际检验医学杂志,2020,78(7):79-83.
21 O'Mahony CM,Clarke G,Gibney S,et al.Strain differences in the neurochemical response to chronic restraint stress in the rat:relevance to depression[J].Pharmacol Biochem Behav,2011,97(4):690-699.
22 Winter G,Hart RA,Charlesworth RPG,et al.Gut microbiome and depression:what we know and what we need to know[J].Rev Neurosci,2018,29(6):629-643.
23 Lach G,Schellekens H,Dinan TG,et al.Anxiety,depression,and the microbiome:a role for gut peptides[J].Neurotherapeutics,2018,15(1):36-59.
24 Paulsen JA,Ptacek TS,Carter SJ,et al.Gut microbiota composition associated with alterations in cardiorespiratory fitness and psychosocial outcomes among breast cancer survivors[J].Support Care Cancer,2017,25(4):1563-1570.
25 Song BC,Bai J.Microbiome-gut-brain axis in cancer treatment-related psychoneurological toxicities and symptoms:a systematic review[J].Support Care Cancer,2021,29(2):605-617.
26 Gareau MG,Wine E,Rodrigues DM,et al.Bacterial infection causes stress-induced memory dysfunction in mice[J].Gut,2018,60(3):307-317.
27 王立宽,程彤,武海崟,等.肠道菌群与围术期神经认知障碍研究进展[J].国际麻醉学与复苏杂志,2021,63(3):23-29.
28 Donovan HS,Hagan TL,Campbell GB,et al.Nausea as a sentinel symptom for cytotoxic chemotherapy effects on the gut-brain axis among women receiving treatment for recurrent ovarian cancer:an exploratory analysis[J].Support Care Cancer,2016,24(6):2635-2642.
29 彭维,申治富,王亚楠,等.肠道菌群对睡眠调节的研究进展[J].重庆医学,2019,31(19):32-36.
30 胡裕洁,杨国帅,王淑玲,等.睡眠障碍相关认知障碍机制研究进展[J].医学综述,2020,28(24):45-50.
31 Loman BR,Jordan KR,Haynes B,et al.Chemotherapy-induced neuroinflammation is associated with disrupted colonic and bacterial homeostasis in female mice[J].Sci Rep,2019,9(1):16490.

[1]	ZHU Kaibin, HE Changjun, CHEN Lantao, KONG Xianglong, ZHAO Su, XU Shidong. Tumor-associated macrophages promotes non-small cell lung cancer growth and tumor vascularization via PLGF/Flt-1 and TGF-β1 signal pathway [J]. Journal of Practical Oncology, 2022, 36(5): 391-397.
[2]	MIN Zhiqian, JIN Ronghui, CHEN Lihong, LEI Xiaoyan, ZHANG Xin, ZHANG Bin, YU Jiao, LIN Lili, CHEN Xiaolong. Application of multimodal MRI in predicting parauterine invasion of stage IB1–IIA2 cervical cancer [J]. Journal of Practical Oncology, 2022, 36(5): 424-428.
[3]	SUN Xinglu, CHEN Che. Research progress of Egr1 in liver cancer [J]. Journal of Practical Oncology, 2022, 36(5): 435-439.
[4]	WANG Xinghan, LV Yalei. Mechanisms of trastuzumab resistance and post-resistance treatment strategies in HER2-positive breast cancer [J]. Journal of Practical Oncology, 2022, 36(5): 445-451.
[5]	LI Xiong, JIANG Wenkai, LANG Zekun, RUI Shaozhen. Research progress on the relationship between tumor-associated neutrophils and pancreatic cancer [J]. Journal of Practical Oncology, 2022, 36(5): 458-462.
[6]	LIU Qianqian, SHANG Lihua. Research progress on the correlation between immune-related adverse reactions and efficacy of immunotherapy in advanced non-small cell lung cancer [J]. Journal of Practical Oncology, 2022, 36(5): 463-467.
[7]	KANG Ziman, YANG Danlin, SUN Jiannan. Progress of breast MRI image texture analysis in breast cancer [J]. Journal of Practical Oncology, 2022, 36(5): 472-476.
[8]	LI Zhihui, LI Zhigao. Research progress of T-DM1 in treatment of HER2 positive breast cancer [J]. Journal of Practical Oncology, 2022, 36(5): 477-482.
[9]	ZHAO Yaru, WU Yun. Research status of common biomarkers and corresponding targeted therapy for gastric cancer [J]. Journal of Practical Oncology, 2022, 36(5): 483-488.
[10]	NA Jun, AN Xiaoxia, LI Xun, ZHANG Weiwei, MU Huijuan, LI Yanxia, PAN Guowei, LIU Li. Analysis of 10-year survival rate of liver cancer among residents in three cities of Liaoning province from 2000 to 2002 [J]. Journal of Practical Oncology, 2022, 36(4): 293-298.
[11]	LIU Chunxun, WANG Peng, ZHAO Haoran, ZHANG Yubao. Mortality trends of biliary tract cancer in China from 1990 to 2019 based on an age-period-cohort model [J]. Journal of Practical Oncology, 2022, 36(4): 299-303.
[12]	LI Xinlin, ZHOU Jinyi, HAN Renqiang, CAI Bo, XU Hong, HAN Yingying. Analysis of epidemiological characteristics of lung cancer in Nantong City from 2013 to 2017 [J]. Journal of Practical Oncology, 2022, 36(4): 304-309.
[13]	SUN Weiling, ZHANG Minghui, WU Huaxing, ZHAO Yanbin. Predictive value of serum tumor markers in histopathological types of bronchoscopy biopsy in patients with lung cancer [J]. Journal of Practical Oncology, 2022, 36(4): 316-322.
[14]	ZHAO Shengwen, WU Tong. Short-term efficacy and safety of ¹³¹I combined with apatinib in the treatment of differentiated thyroid cancer with lung metastasis [J]. Journal of Practical Oncology, 2022, 36(4): 323-326.
[15]	CHEN Jiayi, BAI Yanling. The influence of body mass index and body position fixation in breast cancer patients post-operative intensity modulated radiation therapy setup error [J]. Journal of Practical Oncology, 2022, 36(4): 327-331.

Research progress on the relationship between perioperative intestinal flora and neuropsychiatric symptoms in cancer patients

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments